Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 501-509

  Yamagishi, Sho Ichi ^a   Yonekura, Hideto ^a   Yamamoto, Yasuhiko ^a   Fujimori, Hideki ^a   Sakurai, Shigeru ^a   Tanaka, Nobushige ^a   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DNA SYNTHESIS; GENE EXPRESSION; HYPOXIA; NONHUMAN; OXYGEN TENSION; PERICYTE; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELL DIVISION; CELL HYPOXIA; CELLS, CULTURED; CHEMOTAXIS; DNA; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDE PROBES; PERICYTES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032932547     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adamis AP, Miller JW, Bernai MT, D'Amico DJ, Folkman J, Yeo TK, and Yeo KT (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450.
2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, and King GL (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
3. Beck L and D'Amore PA (1997). Vascular development: Cellular and molecular regulation. FASEB J 11:365-373.
4. Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, and Iruela-Arispe ML (1997). Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab Invest 76:245-255.
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A (1996a). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
6. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Müller M, Risau W, Edgington T, and Collen D (1996b). Role of tissue factor in embryonic blood vessel development. Nature 383:73-75.
7. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, and Trimble ER (1992). The effect of endothelin 1 on the retinal microvascular pericytes. Microvasc Res 43:241-254.
8. D'Amore PA and Thompson RW (1987). Mechanism of angiogenesis. Annu Rev Physiol 49:453-464.
9. Feinberg AP and Vogelstein B (1983). A technique for radio-labeling DNA restriction endonuclease fragments to high specific activities. Anal Biochem 132:6-13.
10. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
11. Ferrara N, Houck KA, Jakeman LB, Winer J, and Leung DW (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218.
12. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, and Del Rosso M (1988). Interaction of urokinase with specific receptors stimulates mobilization of bovine capillary endothelial cells. Exp Cell Res 187:33-38.
13. Folkman J and Haudenschild C (1980). Angiogenesis in vitro. Nature 288:551-556.
14. Folkman J and Shing Y (1992). Angiogenesis. J Biol Chem 267:10931-10934.
15. Fong GH, Rossant J, Gertsenstein M, and Breitman ML (1995). Role of flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
16. Gabrilovich DI, Chen HL, Girgis KR, Cunningham T, Meny GM, Nadaf S, Kavanaugh D, and Carbone DP (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096-1103.
17. Herman IM and D'Amore PA (1985). Microvascular pericytes contain muscle and non-muscle actin. J Cell Biol 101:43-52.
18. Hirschi KK and D'Amore PA (1996). Pericytes in microvasculature. Cardiovasc Res 32:687-698.
19. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, and Leung DW (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
20. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, and Ross R (1992). Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416.
21. Joyce NC, Haire MF, and Palade GE (1985). Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations. J Cell Biol 100:1387-1395.
22. Kolb AJ (1994). The role of microplate selection and assay design in the application of automation and robotics. Lab Inform Manage 26:107-113.
23. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
24. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, and Betsholtz C (1994). Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887.
25. Lindahl P, Johansson BR, Levéen P, and Betsholtz C (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
26. Mandriota SJ, Menoud PA, and Pepper MS (1996). Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271:11500-11505.
27. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, and Yamamoto H (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270:28316-28324.
28. Orlidge A and D'Amore PA (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455-1462.
29. Sato Y and Rifkin DB (1988). Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107:1199-1205.
30. Schlondorff D (1987). The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281.
31. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, and Sibuya M (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135-147.
32. Shepro D and Morel NM (1993). Pericyte physiology. FASEB J 7:1031-1038.
33. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushima H, and Sato M (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519-524.
34. Swinscoe JC and Carlson EC (1992). Capillary endothelial cells secrete a heparin-binding mitogen for pericytes. J Cell Sci 103:453-461.
35. Takagi H, King JL, and Aiello LP (1996). Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45:1016-1023.
36. Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, Kawamura T, Matsumura O, Mitarai T, and Sakai O (1995). Protein tyrosine kinase expressed in glomeruli and cultured glomerular cells: FLT-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 209: 218-226.
37. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowics D, and Böhlen P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586.
38. Vries CD, Escobedo JA, Ueno H, Houck KA, Ferrara N, and Williams LT (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
39. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, and Heldin CH (1994). Differential signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
40. Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, and Yamamoto H (1998). Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41:1435-1441.
41. Yamagishi S, Hsu CC, Kobayashi K, and Yamamoto H (1993a). Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochem Biophys Res Commun 191:840-846.
42. Yamagishi S, Hsu CC, Taniguchi M, Harada S, Yamamoto Y, Ohsawa K, Kobayashi K, and Yamamoto H (1995). Receptor-mediated toxicity to pericytes of advanced glycosylation end products: A possible mechanism of pericyte loss in diabetic microangiopathy. Biochem Biophys Res Commun 213:681-687.
43. Yamagishi S, Kobayashi K, and Yamamoto H (1993b). Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem Biophys Res Commun 190:418-425.
44. Yamagishi S, Yamamoto Y, Harada S, Hsu CC, and Yamamoto H (1996). Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors. FEBS Lett 384:103-106.
45. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, and Yamamoto H (1997). Advanced glycation endproducts-driven angiogenesis in vitro: Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723-8730.
46. Yamamoto H (1995). "Vascular VEGF" in hypoxia-induced proliferation of vascular cells. Microcirc Annu 11:11-12.
47. Yamamoto Y, Yamagishi S, Hsu CC, and Yamamoto H (1996). Advanced glycosylation end products-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B. Biochem Biophys Res Commun 222:700-705.